Drawing for OCTET

USPTO serial 97139085

OCTET

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HETZEL, DANNEAN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with OCTET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan E. Spitz

Megan E. Spitz BLANK ROME LLPOne Logan Square, 130 N. 18th StreetPhiladelphia, PA 19103United States

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in industry and science; biological preparations for use in industry and science; diagnostic preparations other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical reagents for non-medical purposes, namely, for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates and functional properties of biomolecules, namely, chemical compounds, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, virus, bacteria, antibodies and antibody fragments; diagnostic kits, for non-medical purposes, consisting primarily of monoclonal antibodies, buffers, and reagents for testing the presence or absence, concentration, association, affinity, binding rates and functional properties of biomolecules, namely, chemical compounds, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, virus, bacteria, antibodies and antibody fragments; assay kits comprised of biosensors and biomolecular reagents, for non-medical purposes or veterinary use, namely, for analyzing chemical and biological samples for the presence or absence, concentration, association, affinity, binding rates and functional properties of biomolecules, namely, chemical compounds, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, virus, bacteria, antibodies and antibody fragmentsACTIVE—
009optical apparatus and instruments, namely, optical sensors, microscopes, biological microscopes and automated microscopes; interferometers; fiber optic instruments in the nature of biosensors; surface plasmon resonance spectrometers; laboratory apparatus and instruments, namely, cell culture apparatus for laboratory use, namely, cell culture dishes, flasks, and plates; automated dispenser of sterile solutions for laboratory or scientific use; gene amplification laboratory equipment; laboratory apparatus for general research uses, namely, flow cell analysers and coated probes for use with flow cell analysers, for detecting and monitoring biofilm formation; plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic apparatus and instruments, not for medical use, namely, diagnostic biomolecule and DNA sequence detection devices for scientific research purposes; measuring apparatus and instruments for testing the presence or absence, amount and activity of chemical and biological samples, not for medical use, for scientific and laboratory use; downloadable and recorded software for use in the acquisition, analysis, and evaluation of biopharmaceutical, biological and biomolecular data; downloadable and recorded computer software for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, virus, bacteria, antibodies and antibody fragments; biosensors for biological, biomolecular, and biopharmaceutical applications; biosensors for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, virus, bacteria, antibodies and antibody fragments for scientific and laboratory use; fiber optic instruments in the nature of biosensors for use in biomolecular measurement, quantification, kinetics, protein analysis, clinical research applications, drug development and nucleic acid interaction, antibody and antibody fragment characterization, protein-protein interactions, protein-peptide interactions, protein-DNA/RNA interactions, protein-lipid interactions, virus and vaccine research, protein-small molecule interactions for scientific and laboratory useACTIVE—
037installation, cleaning, repair and maintenance of scientific and laboratory apparatus and instruments, namely, flow cell analysers, plates, glass slides or chips having multi-well arrays, interferometers, apparatus for measuring the presence or absence, amount and activity of chemical and biological samples, diagnostic biomolecule and DNA sequence detection devices for scientific research purposes; installation, cleaning, repair and maintenance of diagnostic apparatus and instruments, namely, diagnostic biomolecule and DNA sequence detection devices for scientific research purposes; installation, cleaning, repair and maintenance of sensors, detectors and monitoring instruments, namely, biosensors for biological, biomolecular, and biopharmaceutical applications; advisory services relating to the installation, cleaning, repair and maintenance of scientific and laboratory apparatus and instruments, diagnostic apparatus and instruments, and sensors, detectors and monitoring apparatus and instruments, namely, biosensors for biological, biomolecular, and biopharmaceutical applications and diagnostic biomolecule and DNA sequence detection devices for scientific research purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2026EX4GSOU EXTENSION 4 GRANTED—
May 18, 2026EXT4SOU EXTENSION 4 FILED—
May 18, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 1, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 1, 2025EXT3SOU EXTENSION 3 FILED—
Dec 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2025EX2GSOU EXTENSION 2 GRANTED—
May 16, 2025EXT2SOU EXTENSION 2 FILED—
May 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 22, 2024EX1GSOU EXTENSION 1 GRANTED—
Nov 22, 2024EXT1SOU EXTENSION 1 FILED—
Nov 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 16, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 16, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Mar 16, 2023CNSLSUSPENSION LETTER WRITTEN—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2022DOCKASSIGNED TO EXAMINER—
Nov 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance